(ARWR) Arrowhead - Performance -35.2% in 12m
ARWR performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-76.41%
#121 in Peer-Group
Rel. Strength
14.70%
#6537 in Stock-Universe
Total Return 12m
-35.19%
#105 in Peer-Group
Total Return 5y
-60.31%
#70 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 111 |
| High / Low | USD |
|---|---|
| 52 Week High | 29.54 USD |
| 52 Week Low | 9.99 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 92.89 |
| Buy/Sell Signal +-5 | -0.38 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ARWR (-35.2%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ARWR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARWR
| Total Return (including Dividends) | ARWR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 9.38% | 3.15% | 4.01% |
| 3 Months | 55.30% | 17.08% | 17.14% |
| 12 Months | -35.19% | -11.14% | 13.46% |
| 5 Years | -60.31% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | ARWR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 70.5% | 52.1% | 90.3% |
| 3 Months | 86.9% | 79.4% | 97.5% |
| 12 Months | -82.2% | -87.4% | 46.4% |
| 5 Years | -91.1% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th71.50 | 6.04% | 5.16% |
| 3 Month | %th78.00 | 32.64% | 32.57% |
| 12 Month | %th48.00 | -27.06% | -42.88% |
| 5 Years | %th65.50 | -49.14% | -81.34% |
FAQs
Does Arrowhead (ARWR) outperform the market?
No,
over the last 12 months ARWR made -35.19%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months ARWR made 55.30%, while XBI made 17.08%.
Performance Comparison ARWR vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ARWR vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 8.3% | 5.4% | -11.1% | -49% |
| US NASDAQ 100 | QQQ | 8.3% | 5.2% | -13.1% | -48% |
| German DAX 40 | DAX | 7.9% | 8.2% | -23.2% | -65% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 7.1% | 4.8% | -15.5% | -54% |
| Hongkong Hang Seng | HSI | 7.4% | 6.6% | -33.1% | -70% |
| India NIFTY 50 | INDA | 9.6% | 10.2% | -11.5% | -32% |
| Brasil Bovespa | EWZ | 12.5% | 10% | -26.1% | -37% |
ARWR vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 9.7% | 7.7% | -14.4% | -59% |
| Consumer Discretionary | XLY | 7.3% | 6% | -3.4% | -53% |
| Consumer Staples | XLP | 10.3% | 9.5% | -10.1% | -43% |
| Energy | XLE | 5.3% | 5.3% | -3.5% | -37% |
| Financial | XLF | 9.7% | 6.8% | -13.4% | -61% |
| Health Care | XLV | 8.1% | 9.3% | 0.4% | -29% |
| Industrial | XLI | 7.9% | 4.9% | -16.9% | -59% |
| Materials | XLB | 7.6% | 4.9% | -11.7% | -39% |
| Real Estate | XLRE | 8.5% | 9.5% | -9.6% | -43% |
| Technology | XLK | 8.4% | 2.8% | -16.2% | -46% |
| Utilities | XLU | 8.2% | 6.8% | -15.1% | -55% |
| Aerospace & Defense | XAR | 7.6% | 2.5% | -31.1% | -84% |
| Biotech | XBI | 4.6% | 6.2% | -0.8% | -24% |
| Homebuilder | XHB | 5.2% | 0.6% | -4.5% | -34% |
| Retail | XRT | 8.3% | 6.1% | -6.2% | -42% |
ARWR vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 7.7% | 6.08% | 2.84% | -31% |
| Natural Gas | UNG | 10% | 15.8% | 14.9% | -33% |
| Gold | GLD | 8.2% | 9.1% | -29% | -74% |
| Silver | SLV | 3.9% | 3.1% | -33.1% | -57% |
| Copper | CPER | -2.1% | -5.6% | -30.6% | -59% |
ARWR vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 9.1% | 9.4% | -5.8% | -31% |
| iShares High Yield Corp. Bond | HYG | 8.8% | 8.3% | -8.1% | -44% |